According to Caccamo et al. [173], an increase in the expression of necroptosis markers was observed in the brain of AD patients, and the activation of necroptosis in APP/PS1 transgenic mice with AD increased cognitive impairment. This evidence concerns the gene APP and Alzheimer disease.